Antman
et al., Management
of Patients With STEMI: Executive Summary
J
Am Coll Cardiol 2004;44:671-719
ACC/AHA
Guidelines for the Management of Patients With ST-Elevation Myocardial
Infarction—Executive Summary
A
Report of the American College of Cardiology/American Heart Association
Task Force on Practice Guidelines (Writing Committee to Revise the
1999 Guidelines for the Management of Patients With Acute Myocardial
Infarction)
Developed
in Collaboration With the Canadian Cardiovascular Society
Prehospital Issues
A. Emergency Medical Services Systems
Class I
1. All EMS first responders who respond to patients with
chest pain and/or suspected cardiac arrest should be trained and
equipped to provide early defibrillation. (Level of Evidence:
A)
2. All public safety first responders who respond to patients with
chest pain and/or suspected cardiac arrest should be trained and
equipped to provide early defibrillation with AEDs. (Provision of
early defibrillation with AEDs by nonpublic safety first responders
is a promising new strategy, but further study is needed to determine
its safety and efficacy.) (Level of Evidence: B)
3. Dispatchers staffing 9-1-1 center emergency medical calls should
have medical training, should use nationally developed and maintained
protocols, and should have a quality-improvement system in place
to ensure compliance with protocols. (Level of Evidence: C)
Early access to EMS is promoted by a 9-1-1 system currently available
to more than 90% of the US population. To minimize time to treatment,
particularly for cardiopulmonary arrest, many communities allow
volunteer and/or paid firefighters and other first-aid providers
to function as first responders, providing CPR and, increasingly,
early defibrillation using automated external defibrillators (AEDs)
until emergency medical technicians and paramedics arrive. Most
cities and larger suburban areas provide EMS ambulance
services
with providers from the fire department, a private ambulance company,
and/or volunteers.
B. Prehospital Chest Pain Evaluation and
Treatment
Class I
1. Prehospital EMS providers should administer 162 to 325
mg of aspirin (chewed) to chest pain patients suspected of having
STEMI unless contraindicated or already taken by patient. Although
some trials have used enteric-coated aspirin for initial dosing,
more rapid buccal absorption occurs with non–enteric-coated
formulations. (Level of Evidence: C)
Class IIa
1. It is reasonable for all 9-1-1 dispatchers to advise
patients without a history of aspirin allergy who have symptoms
of STEMI to chew aspirin (162 to 325 mg) while awaiting arrival
of prehospital EMS providers. Although some trials have used enteric-coated
aspirin for initial dosing, more rapid buccal absorption occurs
with non–enteric-coated formulations. (Level of Evidence:
C)
2. It is reasonable that all ACLS providers perform and evaluate
12-lead electrocardiograms (ECGs) routinely on chest pain patients
suspected of STEMI. (Level of Evidence: B)
3. If the ECG shows evidence of STEMI, it is reasonable that prehospital
ACLS providers review a reperfusion “checklist” and
relay the ECG and checklist findings to a predetermined medical
control facility and/or receiving hospital. (Level of Evidence:
C)
It is reasonable for physicians to encourage the prehospital
administration of aspirin via EMS personnel (ie, EMS dispatchers
and providers) in patients with symptoms suggestive of STEMI unless
its use is contraindicated (22).
For patients who have ECG evidence of STEMI, it is reasonable that
paramedics review a reperfusion checklist and relay the ECG and
checklist findings to a predetermined medical control facility and/or
receiving hospital.
C. Prehospital Fibrinolysis
Class IIa
1. Establishment of a prehospital fibrinolysis protocol is reasonable
in 1) settings in which physicians are present in the ambulance
or in 2) well-organized EMS systems with full-time paramedics who
have 12-lead ECGs in the field with transmission capability, paramedic
initial and ongoing training in ECG interpretation and STEMI treatment,
online medical command, a medical director with training/experience
in STEMI management, and an ongoing continuous quality-improvement
program. (Level of Evidence: B)
Randomized controlled trials of fibrinolytic therapy have demonstrated
the benefit of initiating fibrinolytic therapy as early as possible
after onset of ischemic-type chest discomfort (Figure
1) (23–25).
It appears reasonable to expect that if fibrinolytic
therapy could be started at the time of prehospital evaluation,
a greater number of lives could be saved. Prehospital fibrinolysis
is reasonable in those settings in which physicians are present
in the ambulance or prehospital transport times are more than 60
minutes in high-volume (more than 25,000 runs per year) EMS systems
(26). Other considerations for implementing
a prehospital fibrinolytic service include the ability to transmit
ECGs, paramedic initial and ongoing training in ECG interpretation
and myocardial infarction (MI) treatment, online medical command,
a medical director with training/experience in management of STEMI,
and full-time paramedics (27).
D. Prehospital Destination Protocols
Class I
1. Patients with STEMI who have cardiogenic shock and are less than
75 years of age should be brought immediately or secondarily transferred
to facilities capable of cardiac catheterization and rapid revascularization
(percutaneous coronary intervention [PCI] or coronary artery bypass
graft surgery [CABG]) if it can be performed within 18 hours of
onset of shock. (Level of Evidence: A)
2. Patients with STEMI who have contraindications to fibrinolytic
therapy should be brought immediately or secondarily transferred
promptly (ie, primaryreceiving hospital door-to-departure time less
than 30 minutes) to facilities capable of cardiac catheterization
and rapid revascularization (PCI or CABG). (Level of Evidence:
B)
3. Every community should have a written protocol that guides EMS
system personnel in determining where to take
patients with suspected or confirmed STEMI. (Level of Evidence:
C)
Class IIa
1. It is reasonable that patients with STEMI who have cardiogenic
shock and are 75 years of age or older be considered for immediate
or prompt secondary transfer to facilities capable of cardiac catheterization
and rapid revascularization (PCI or CABG) if it can be performed
within 18 hours of onset of shock. (Level of Evidence: B)
2. It is reasonable that patients with STEMI who are at especially
high risk of dying, including those with severe congestive heart
failure (CHF), be considered for immediate or prompt secondary transfer
(i.e., primary-receiving hospital door-to-departure time less than
30 minutes) to facilities capable of cardiac catheterization and
rapid revascularization (PCI or CABG). (Level of Evidence: B)
Every community should have a written protocol that guides EMS system
personnel in determining where to take patients with suspected or
confirmed STEMI. Active involvement of local healthcare providers,
particularly cardiologists and emergency physicians, is needed to
formulate local EMS destination protocols for these patients. In
general, patients with suspected STEMI should be taken to the nearest
appropriate hospital. However, patients with STEMI and shock are
an exception to this general rule. Whenever possible, STEMI patients
less than 75 years of age with shock should be transferred to facilities
capable of cardiac catheterization and rapid revascularization (PCI
or CABG). On the basis of observations in the SHOCK Trial Registry
and other registries, it is reasonable to extend such considerations
of transfer to invasive centers for elderly patients with shock
(see VII.F.5 and Section 7.6.5 of the full-text guidelines). Patients
with STEMI who have contra-indications to fibrinolytic therapy should
be brought immediately or secondarily transferred promptly (i.e.,
primary-receiving hospital door-to-departure time less than 30 minutes)
to facilities capable of cardiac catheterization and rapid revascularization
(PCI or CABG). |